Related Experiment Video
Updated: May 12, 2025
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their
Kathleen Wee1, Kevin C Yang1, David F Schaeffer2,3
1Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Abstract:
Neuroendocrine neoplasms (NENs) encompass a highly heterogeneous group of neoplasms with varying prognoses and molecular alterations. Molecular profiling studies have furthered our understanding of NENs, but the majority of previous studies have focused on primary tumors and on mutational landscapes using DNA sequencing data. Here, we describe the genomic and transcriptomic landscapes of 28 metastatic NENs across different primary anatomical sites (PASs) and their potential clinical implications. Although our cohort is small, our analyses provide further insights on the molecular commonalities and distinctions between metastatic NENs of different PASs. Comparison to several reference transcriptome data sets revealed that despite considerable whole genome and transcriptome variability in NENs, the metastatic NENs are still more like each other than other cancer types. Our study also highlights the potential utility of NEN transcriptome data for molecular classification and clinical decision making.
Insights
This study reveals molecular commonalities and distinctions in metastatic neuroendocrine neoplasms (NENs) across various primary sites. Transcriptome data offers potential for NEN classification and clinical decisions.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Neuroendocrine neoplasms (NENs) are a heterogeneous cancer group with diverse prognoses.
- Previous research primarily focused on primary tumors and DNA mutations, limiting understanding of metastatic NENs.
- Genomic and transcriptomic variability exists within NENs.
Purpose of the Study:
- To investigate the genomic and transcriptomic landscapes of metastatic NENs from different primary anatomical sites (PASs).
- To identify molecular commonalities and distinctions among metastatic NENs.
- To explore the clinical implications of NEN transcriptome data for classification and decision-making.
Main Methods:
- Analysis of genomic and transcriptomic data from 28 metastatic NENs.
- Comparison of NEN transcriptomes with reference datasets from other cancer types.
- Evaluation of potential clinical utility of transcriptome data.
Main Results:
- Identified shared and distinct molecular features in metastatic NENs across different PASs.
- Demonstrated that metastatic NENs share more molecular similarities with each other than with other cancer types, despite overall variability.
- Highlighted the potential of NEN transcriptome data for molecular classification.
Conclusions:
- Metastatic NENs exhibit unique molecular characteristics that distinguish them from other cancers.
- Transcriptome profiling provides valuable insights into NEN heterogeneity and potential therapeutic targets.
- NEN transcriptome data can aid in molecular classification and inform clinical decision-making for improved patient outcomes.
